118 related articles for article (PubMed ID: 19212940)
1. Verapamil in treatment resistant depression: a role for the P-glycoprotein transporter?
Clarke G; O'Mahony SM; Cryan JF; Dinan TG
Hum Psychopharmacol; 2009 Apr; 24(3):217-23. PubMed ID: 19212940
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of P-glycoprotein enhances transport of imipramine across the blood-brain barrier: microdialysis studies in conscious freely moving rats.
O'Brien FE; Clarke G; Fitzgerald P; Dinan TG; Griffin BT; Cryan JF
Br J Pharmacol; 2012 Jun; 166(4):1333-43. PubMed ID: 22250926
[TBL] [Abstract][Full Text] [Related]
3. Influence of P-glycoprotein inhibition on the distribution of the tricyclic antidepressant nortriptyline over the blood-brain barrier.
Ejsing TB; Linnet K
Hum Psychopharmacol; 2005 Mar; 20(2):149-53. PubMed ID: 15624117
[TBL] [Abstract][Full Text] [Related]
4. Imipramine distribution among red blood cells, plasma and brain tissue.
Fisar Z; Krulik R; Fuksová K; Sikora J
Gen Physiol Biophys; 1996 Feb; 15(1):51-64. PubMed ID: 8902557
[TBL] [Abstract][Full Text] [Related]
5. Can celecoxib affect P-glycoprotein-mediated drug efflux? A microPET study.
de Vries EF; Doorduin J; Vellinga NA; van Waarde A; Dierckx RA; Klein HC
Nucl Med Biol; 2008 May; 35(4):459-66. PubMed ID: 18482683
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the uptake of dextromethorphan in the CNS of rats by concomitant administration of the P-gp inhibitor verapamil.
Marier JF; Deschênes JL; Hage A; Seliniotakis E; Gritsas A; Flarakos T; Beaudry F; Vachon P
Life Sci; 2005 Oct; 77(23):2911-26. PubMed ID: 15964599
[TBL] [Abstract][Full Text] [Related]
7. [Ca(2+)-channel blockers and binding of tricyclic antidepressive agents].
Krulík R; Bures P; Fisar Z; Fuksová K; Sikora J; Beitlová D
Cesk Psychiatr; 1995 Jul; 91(3):143-51. PubMed ID: 7553947
[TBL] [Abstract][Full Text] [Related]
8. Calcium-channel blocker verapamil administration in prolonged and refractory status epilepticus.
Iannetti P; Spalice A; Parisi P
Epilepsia; 2005 Jun; 46(6):967-9. PubMed ID: 15946342
[TBL] [Abstract][Full Text] [Related]
9. Verapamil is not an antidepressant in patients resistant to tricyclic antidepressants.
Adlersberg S; Toren P; Mester R; Rehavi M; Skolnick P; Weizman A
Clin Neuropharmacol; 1994 Jun; 17(3):294-7. PubMed ID: 9316675
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine.
Daniel W; Syrek M; Janczar L; Boksa J
Pol J Pharmacol; 1995; 47(2):127-36. PubMed ID: 8688885
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in capillary density, perfusion rate, and P-glycoprotein activity: a quantitative analysis of regional drug exposure in the brain.
Zhao R; Pollack GM
Biochem Pharmacol; 2009 Oct; 78(8):1052-9. PubMed ID: 19523457
[TBL] [Abstract][Full Text] [Related]
12. The effect of infliximab on hepatic cytochrome P450 and pharmacokinetics of verapamil in rats with pre-adjuvant arthritis: a drug-disease and drug-drug interaction.
Ling S; Jamali F
Basic Clin Pharmacol Toxicol; 2009 Jul; 105(1):24-9. PubMed ID: 19371259
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive investigation of plasma and brain regional pharmacokinetics of imipramine and its metabolites during and after chronic administration in the rat.
Besret L; Debruyne D; Rioux P; Bonvalot T; Moulin M; Zarifian E; Baron JC
J Pharm Sci; 1996 Mar; 85(3):291-5. PubMed ID: 8699331
[TBL] [Abstract][Full Text] [Related]
14. Modification of tricyclic antidepressant analgesia by calcium channel blockers.
Muthal AV; Chopde CT
Indian J Physiol Pharmacol; 1993 Jul; 37(3):238-40. PubMed ID: 8276505
[TBL] [Abstract][Full Text] [Related]
15. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
[TBL] [Abstract][Full Text] [Related]
16. Verapamil for cluster headache. Clinical pharmacology and possible mode of action.
Tfelt-Hansen P; Tfelt-Hansen J
Headache; 2009 Jan; 49(1):117-25. PubMed ID: 19125880
[TBL] [Abstract][Full Text] [Related]
17. [Anticalcium activity of several antidepressive agents].
Andreeva NI; Golovina SM; Rumiantsev EA; Mashkovskiĭ MD
Biull Eksp Biol Med; 1992 May; 113(5):502-4. PubMed ID: 1421269
[TBL] [Abstract][Full Text] [Related]
18. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y modulates the antidepressant activity of imipramine in olfactory bulbectomized rats: involvement of NPY Y1 receptors.
Goyal SN; Upadhya MA; Kokare DM; Bhisikar SM; Subhedar NK
Brain Res; 2009 Apr; 1266():45-53. PubMed ID: 19254701
[TBL] [Abstract][Full Text] [Related]
20. Comparison of fused-core and conventional particle size columns by LC-MS/MS and UV: application to pharmacokinetic study.
Song W; Pabbisetty D; Groeber EA; Steenwyk RC; Fast DM
J Pharm Biomed Anal; 2009 Oct; 50(3):491-500. PubMed ID: 19540084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
